Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The presence of yeasts and bacteria in free-living amoebae isolated from COVID-19 patients: concern for secondary infections.
Mirabedini Z, Niyyati M, Mohammad Rahimi H, Soleimani Jevinani S, Fatemi M, Tanhaei M, Mohebbi SR, Yadegar A, Abolghasemi S, Arab Mazar Z, Mirjalali H. Mirabedini Z, et al. Among authors: abolghasemi s. Int J Environ Health Res. 2024 Oct 20:1-14. doi: 10.1080/09603123.2024.2409830. Online ahead of print. Int J Environ Health Res. 2024. PMID: 39428626
Comparison of the Efficacy of Povidone-Iodine with Mupirocin in Decolo-nizing Staphylococcus aureus from the Nasal Cavity of Healthcare Work-ers: A Single-Blinded Randomized Controlled Trial.
Abolghasemi S, Ghazi M, Ziaie S, Mahboubi A, Gachkar L, Keyvanfar A, Naeimipoor M. Abolghasemi S, et al. Infect Disord Drug Targets. 2024 Sep 20. doi: 10.2174/0118715265301671240910070901. Online ahead of print. Infect Disord Drug Targets. 2024. PMID: 39313892 Clinical Trial.
Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial.
Yadegarynia D, Keyvanfar A, Keyvani H, Tehrani S, Sali S, Abolghasemi S. Yadegarynia D, et al. Among authors: abolghasemi s. Vaccine. 2024 Apr 2;42(9):2254-2259. doi: 10.1016/j.vaccine.2024.02.073. Epub 2024 Feb 29. Vaccine. 2024. PMID: 38423811 Clinical Trial.
Assessment of Effectiveness and Adverse Effect of New Combination Chemotherapy (irinotecan, cisplatin, and dexamethasone) in Relapse and Refractory Hodgkin Lymphoma.
Tabarraee M, Rezaee A, Abolghasemi S, Ghadiany M, Tavakoli Ardakani M, Mahdizadeh M, Hamidi N, Ghasemi K. Tabarraee M, et al. Among authors: abolghasemi s. Int J Hematol Oncol Stem Cell Res. 2023 Jul 1;17(3):194-199. doi: 10.18502/ijhoscr.v17i3.13309. Int J Hematol Oncol Stem Cell Res. 2023. PMID: 37817972 Free PMC article.
Saffron and Sleep Quality: A Systematic Review of Randomized Controlled Trials.
Sadat Rafiei SK, Abolghasemi S, Frashidi M, Ebrahimi S, Gharei F, Razmkhah Z, Tavousi N, Mahmoudvand B, Faani M, Karimi N, Abdi A, Soleimanzadeh M, Ahmadpour Youshanlui M, Sadatmadani SF, Alikhani R, Pishkari Y, Deravi N. Sadat Rafiei SK, et al. Among authors: abolghasemi s. Nutr Metab Insights. 2023 Jul 18;16:11786388231160317. doi: 10.1177/11786388231160317. eCollection 2023. Nutr Metab Insights. 2023. PMID: 37484523 Free PMC article. Review.
Drug-induced liver injury due to tofacitinib: a case report.
Mardani M, Mohammadshahi J, Abolghasemi S, Teimourpour R. Mardani M, et al. Among authors: abolghasemi s. J Med Case Rep. 2023 Mar 18;17(1):97. doi: 10.1186/s13256-023-03821-4. J Med Case Rep. 2023. PMID: 36932434 Free PMC article.
42 results